tiprankstipranks
Serina Therapeutics (SER)
:SER
US Market

Serina Therapeutics (SER) Income Statement

Compare
193 Followers

Serina Therapeutics Income Statement

Last quarter (Q3 2024), Serina Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Serina Therapeutics's net income was $1.41M. See Serina Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 142.00K$ 500.00K$ 3.04M$ 54.00K$ 1.73M
Gross Profit
$ -29.00K$ 355.00K$ 2.89M$ -1.23M$ 729.50K
Operating Expenses
$ 9.93M$ 2.77M$ 4.67M$ 9.18M$ 13.29M
Depreciation and Amortization
$ 131.00K$ 132.00K$ 131.00K$ 1.25M$ 951.00K
EBITDA
$ -9.78M$ -2.60M$ -1.59M$ -8.74M$ -11.61M
Operating Income
$ -9.96M$ -2.27M$ -1.63M$ -10.41M$ -12.56M
Other Income/Expenses
$ -4.85M$ -411.74K$ 366.81K$ 8.00K$ 323.00K
Pretax Income
$ -14.81M$ -2.68M$ -1.26M$ -10.40M$ -12.24M
Net Income
$ -14.80M$ -2.68M$ -1.26M$ -10.87M$ -12.15M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -13.72$ -2.49$ -1.17$ -10.14$ -11.47
Diluted EPS
$ -13.72$ -2.49$ -1.17$ -10.14$ -11.47
Weighted Average Shares Outstanding
1.08M 1.08M 1.08M 1.07M 1.06M
Weighted Average Shares Outstanding (Diluted)
1.08M 1.08M 1.08M 1.07M 1.06M
Currency in USD

Serina Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis